Novel Targets and Approaches in Cancer Therapy

Dear Colleagues,

Novel targeted therapies and immunotherapies have revolutionized the treatment of various tumor types. The development of next-generation sequencing technologies plays a key role in identifying new targets and advancing precision oncology. Novel targets are still needed to optimize current therapies, identify effective combinations, improve efficacy and address acquired resistance. Furthermore, new innovative strategies are also needed for rare cancers, where the availability of sequencing and other data may be limiting. In this Special Issue of Cancers, we invite research manuscripts and reviews that present novel or improved targets and drugs, new insights into current cancer therapies and related mechanisms, as well as new methods, databases and tools that aid in the identification of targets and the development of targeted therapies and immunotherapies.

Dr. Jason Roszik
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.